Medical and Pharmaceutical New Nova Scotia lung clinic aims to slash years-long waits for breathing tests Respiratory therapy students will administer the tests while a Nova Scotia Health preceptor oversees their work Joseph MortonNovember 17, 2025
Medical and Pharmaceutical BioMark Diagnostics ships liquid biopsy tech to Germany for 10,000-person lung cancer study 'HANSE' is the nation's largest lung cancer trial of all time Rowan DunneNovember 13, 2025
Medical and Pharmaceutical BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing BioMark showed the importance of expanding access to underserved and remote communities Joseph MortonNovember 13, 2025
Medical and Pharmaceutical Malaysian health ministry uses AI to detect 22 lung cancer cases in 2 months The achievement preceded the launch of the nation's LungShield screening campaign Rowan DunneNovember 5, 2025
Medical and Pharmaceutical California kids create US$200 breath analyzer for lung diseases Losing a family member was a key source of inspiration for one of the inventors Rowan DunneOctober 29, 2025
Medical and Pharmaceutical University of Texas develops lung cancer breath analysis system It identifies 8 volatile organic compounds associated with thoracic cancers Rowan DunneOctober 27, 2025
Medical and Pharmaceutical Keensight Capital takes majority stake in breath analysis device maker "Quick and non-invasive breath analysis is the new blood test," says Bedfont Scientific Rowan DunneOctober 23, 2025
Medical and Pharmaceutical Bangladesh school pioneers unique lung cancer breath test It harnesses the power of aluminum-derived nanotubes Rowan DunneOctober 15, 2025
Medical and Pharmaceutical Leading experts exchange lung cancer insights at Vietnam conference Biomarker testing, AI and early detection were key topics this year Rowan DunneOctober 14, 2025
Medical and Pharmaceutical University of Calgary needs your toenail clippings for lung cancer research Toenails have been proven to store lead-210: an isotope linked to radon exposure Rowan DunneOctober 8, 2025